Lilly Halts Development of Alzheimer’s Drug

Posted on August 17, 2010. Filed under: Health, Medical |

By Lewis Krauskopf

NEW YORK | Tue Aug 17, 2010 10:47am EDT

NEW YORK (Reuters) – Eli Lilly and Co is halting development of one of its experimental Alzheimer’s disease treatments after the drug worsened cognition and the ability to perform daily tasks in large late-stage studies.

Separately on Tuesday, U.S. Food and Drug Administration staff raised safety concerns about using Lilly’s blockbuster antidepressant Cymbalta to treat chronic pain ahead of a public meeting on Thursday to weigh the potential new use of the drug.

Full Article



Make a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: